Literature DB >> 4608769

Pindolol: a comparison with other antihypertensive drugs and a double-blind placebo trial.

H J Waal-Manning, F O Simpson.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1974        PMID： 4608769

Source DB:  PubMed          Journal:  N Z Med J        ISSN： 0028-8446


× No keyword cloud information.
  7 in total

1.  Decrease in plasma noradrenaline levels following long-term treatment with prindolol in patients with essential hypertension.

Authors:  H M Brecht; F Banthien; W Schoeppe
Journal:  Klin Wochenschr       Date:  1976-11-15

Review 2.  The second Lilly Prize Lecture, University of Newcastle, July 1977. beta-Adrenergic receptor blockade in hypertension, past, present and future.

Authors:  B N Prichard
Journal:  Br J Clin Pharmacol       Date:  1978-05       Impact factor: 4.335

3.  Experience with beta-adrenoreceptor blockers in hypertension.

Authors:  H Waal-Manning
Journal:  Drugs       Date:  1976       Impact factor: 9.546

4.  Pharmacokinetic comparison of pindolol 30 mg retard and 15 mg normal tablets.

Authors:  W H Aellig; E Nüesch; W Pacha
Journal:  Eur J Clin Pharmacol       Date:  1982       Impact factor: 2.953

5.  Cardiac dose-response relationships of oral and intravenous pindolol.

Authors:  S G Carruthers
Journal:  Br J Clin Pharmacol       Date:  1982       Impact factor: 4.335

Review 6.  Beta-adrenergic receptor blocking drugs in hypertension.

Authors:  F O Simpson
Journal:  Drugs       Date:  1974       Impact factor: 9.546

7.  Atenolol versus pindolol: side-effects in hypertension.

Authors:  E C Foerster; P Greminger; W Siegenthaler; H Vetter; W Vetter
Journal:  Eur J Clin Pharmacol       Date:  1985       Impact factor: 2.953
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.